Literature DB >> 16505613

The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children.

Mark L Everard1.   

Abstract

PURPOSE OF REVIEW: The relationship between respiratory syncytial virus lower-respiratory-tract infections in early childhood and asthma has been the subject of much debate. Most, but not all, previous cohort studies have failed to identify a link between early respiratory syncytial virus infection and atopic asthma. Recent studies have helped clarify some apparently contradictory findings. RECENT
FINDINGS: Cohort studies focusing on wheezing in early childhood have indicated that this is associated with an increased incidence of atopic asthma but that this risk is not increased by respiratory syncytial virus infection. Indeed, wheeze associated with rhinovirus infection may be a better marker for possible asthma. In contrast, there is no increased risk of atopic disease in infants with respiratory syncytial virus 'acute bronchiolitis', a phenotype characterized by widespread crepitation. Post-bronchiolitic symptoms are associated with intercurrent viral infections in particular and the incidence of symptoms falls rapidly during infancy.
SUMMARY: These studies confirm earlier suggestions that the phenotype of respiratory illness and hence the host response rather than the infecting organism is the best predictor of the future pattern of respiratory illness. Such considerations must be central to the design of any future intervention or cohort studies.

Entities:  

Mesh:

Year:  2006        PMID: 16505613     DOI: 10.1097/01.all.0000200506.62048.06

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  16 in total

Review 1.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

2.  Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.

Authors:  Junyan Han; Yi Jia; Katsuyuki Takeda; Yoshiki Shiraishi; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  2010-05-04       Impact factor: 21.405

3.  Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection.

Authors:  Junyan Han; Katsuyuki Takeda; Meiqin Wang; Wanjiang Zeng; Yi Jia; Yoshiki Shiraishi; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

Review 4.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

5.  Role of licochalcone A on thymic stromal lymphopoietin expression: implications for asthma.

Authors:  Sung-Ho Kim; Min Yang; Jian-Gang Xu; Xi Yu; Xue-Jiao Qian
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-23

Review 6.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

7.  A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye.

Authors:  Alla Musiyenko; Lucia Correa; Nicholas Stock; John H Hutchinson; Daniel S Lorrain; Gretchen Bain; Jilly F Evans; Sailen Barik
Journal:  Clin Vaccine Immunol       Date:  2009-09-16

8.  Nitrogen dioxide promotes allergic sensitization to inhaled antigen.

Authors:  Mieke Bevelander; Jana Mayette; Laurie A Whittaker; Sara A Paveglio; Christine C Jones; Justin Robbins; David Hemenway; Shizuo Akira; Satoshi Uematsu; Matthew E Poynter
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 9.  Airway epithelial regulation of allergic sensitization in asthma.

Authors:  Matthew E Poynter
Journal:  Pulm Pharmacol Ther       Date:  2012-05-09       Impact factor: 3.410

10.  The Role of RSV Infection in Asthma Initiation and Progression: Findings in a Mouse Model.

Authors:  Junyan Han; Katsuyuki Takeda; Erwin W Gelfand
Journal:  Pulm Med       Date:  2011-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.